Self-perceived stress among young women was significantly associated with increased risk for early-onset cryptogenic ischemic ...

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

A new study published in the journal of Diabetes Research and Clinical Practice revealed that across all glucose metabolism ...

Not to B-negative, but your blood type could offer a clue to your risk of having a stroke before 60. Researchers at the ...

Ischemic stroke is a fatal condition caused by an arterial embolism that blocks the blood flow through the cerebral artery, frequently being a cause of mortality and disability. Fibroblast growth ...

A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.

There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

Europe, with a global market share of 32.7% in 2022, followed North America in the adoption of ischemic stroke aspiration systems. Germany, with a strong manufacturing industry base, contributed to ...

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

Self-perceived stress is associated with cryptogenic ischemic stroke (CIS), according to a study published online Mar ...